Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency.

Adebayo Ogunniyi; Mabel Rodriguez; Sean Devlin; Nelly Adel; Heather Landau; David J. Chung; Nikoletta Lendvai; Alexander Lesokhin; Guenther Koehne; Sham Mailankody; Neha Korde; Lilian Reich; Ola Landgren; Sergio Giralt; Hani Hassoun

doi:10.1080/10428194.2016.1239261

Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency.

Adebayo Ogunniyi, Mabel Rodriguez, Sean Devlin, Nelly Adel, Heather Landau, David J. Chung, Nikoletta Lendvai, Alexander Lesokhin, Guenther Koehne, Sham Mailankody, Neha Korde, Lilian Reich, Ola Landgren, Sergio Giralt, Hani Hassoun

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Leukemia & Lymphoma
Volume	58
DOIs	https://doi.org/10.1080/10428194.2016.1239261
State	Published - May 4 2017

Disciplines

Medicine and Health Sciences
Endocrinology, Diabetes, and Metabolism
Immunology and Infectious Disease

Access to Document

10.1080/10428194.2016.1239261License: Unspecified

Cite this

Ogunniyi, A., Rodriguez, M., Devlin, S., Adel, N., Landau, H., Chung, D. J., Lendvai, N., Lesokhin, A., Koehne, G., Mailankody, S., Korde, N., Reich, L., Landgren, O., Giralt, S., & Hassoun, H. (2017). Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency. Leukemia & Lymphoma, 58. https://doi.org/10.1080/10428194.2016.1239261

Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency. / Ogunniyi, Adebayo; Rodriguez, Mabel; Devlin, Sean et al.
In: Leukemia & Lymphoma, Vol. 58, 04.05.2017.

Research output: Contribution to journal › Article › peer-review

Ogunniyi, A, Rodriguez, M, Devlin, S, Adel, N, Landau, H, Chung, DJ, Lendvai, N, Lesokhin, A, Koehne, G, Mailankody, S, Korde, N, Reich, L, Landgren, O, Giralt, S & Hassoun, H 2017, 'Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency.', Leukemia & Lymphoma, vol. 58. https://doi.org/10.1080/10428194.2016.1239261

@article{5313c44db8aa48ae878706f9249e58ff,

title = "Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency.",

author = "Adebayo Ogunniyi and Mabel Rodriguez and Sean Devlin and Nelly Adel and Heather Landau and Chung, {David J.} and Nikoletta Lendvai and Alexander Lesokhin and Guenther Koehne and Sham Mailankody and Neha Korde and Lilian Reich and Ola Landgren and Sergio Giralt and Hani Hassoun",

year = "2017",

month = may,

day = "4",

doi = "10.1080/10428194.2016.1239261",

language = "American English",

volume = "58",

journal = "Leukemia & Lymphoma",

}

TY - JOUR

T1 - Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency.

AU - Ogunniyi, Adebayo

AU - Rodriguez, Mabel

AU - Devlin, Sean

AU - Adel, Nelly

AU - Landau, Heather

AU - Chung, David J.

AU - Lendvai, Nikoletta

AU - Lesokhin, Alexander

AU - Koehne, Guenther

AU - Mailankody, Sham

AU - Korde, Neha

AU - Reich, Lilian

AU - Landgren, Ola

AU - Giralt, Sergio

AU - Hassoun, Hani

PY - 2017/5/4

Y1 - 2017/5/4

UR - http://www.tandfonline.com/doi/full/10.1080/10428194.2016.1239261

U2 - 10.1080/10428194.2016.1239261

DO - 10.1080/10428194.2016.1239261

M3 - Article

VL - 58

JO - Leukemia & Lymphoma

JF - Leukemia & Lymphoma

ER -

Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency.

Disciplines

Access to Document

Other files and links

Cite this